CFDA recently organized a 3-day training session on In Vitro Diagnostics Clinical Evaluation and Trials in Beijing. Around 200 industry professionals participated in the event. Representatives from Brandwood Biomedical Beijing joined this session. Key discussions include: Review on In Vitro Diagnostics regulations Requirements on In Vitro Diagnostics Clinical Evaluation Overview of In Vitro Diagnostics Clinical… Learn more
Brandwood Biomedical has been working in Taiwan for several years, including supporting a number of clients in navigating the regulations and post-market requirements. With an increasing population of 23.5 million and a Medical Device market of US $4.7 billion reported in 2016, it’s not surprising that companies are still very interested in entering this lucrative… Learn more
As we watch the changes in Europe evolve under the Medical Devices Regulations (MDR), we are starting to see an increasing trend where companies that had previously used Europe as a fast pass into Australia, starting to go directly to Therapeutic Goods Administration (TGA) for their conformity assessment. Earlier times saw the regulator struggling with… Learn more
China’s 13th National People’s Congress approved a merger of a host of current regulatory agencies – including CFDA, into a new super-ministry for all things regulatory. We take a look at the powers of the new SMRA – or the State Market Regulatory Administration and ask what it means for CFDA’s devices reforms.
At the March 2018 Shanghai meeting of IMDRF, new work item proposals from China on GCP practices and the update of technical standards were approved. These seemingly routine administrative efforts mask a radical change – with China for the first time taking the lead on IMDRF harmonization efforts and seeking to promulgate its own approaches into global regulation. We take a look at what’s really going on.
Don't miss out, watch now...
LIVE WEBINAR: Taiwan FDA has a regulatory process which recognises international approvals and provides some fast track pathways for devices already Learn how you can leverage existing international approvals to smooth the path to this sophisticated and valuable market. Read More
Serving the industry for close to 20 years, we bring a track record and credibility that is second to none. Choose a regulatory partner that combines deep expertise with a flexible, strategic approach and a commercial focus that never loses sight of your objective - market access.
Risk Assessments, Design Controls, Biocompatibility , Clinical Evaluation Reports we can provide comprehensive technical support to ensure compliant product development. We can prepare full regulatory submissions for Medical Devices (including medical software) IVDs and combination products. We have the depth of technical expertise and international experience you need to support your expanding business.
Product recall? Warning Letter? Audit failure? Cancellation of Registration? Don’t Panic! We are experienced in dealing directly with regulators to resolve postmarket issues smoothly and with minimum fuss.
A quality culture adds real value to your business and ensures compliance runs smoothly. Let us help you – with individual processes, independent internal audit support or building a complete system. We are experienced in ISO 13485 and 21CFR 820 (QSR) for design and manufacturer and in ISO 17025 and 21CFR 58 for laboratories.